Obesity and cardiovascular risk
Clinical trials for Obesity and cardiovascular risk explained in plain language.
Never miss a new study
Get alerted when new Obesity and cardiovascular risk trials appear
Sign up with your email to follow new studies for Obesity and cardiovascular risk, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill aims to fight Obesity-Linked inflammation
Disease control OngoingThis study tests an experimental drug called BGE-102 in 160 adults with obesity and heart risk factors. The goal is to see if it lowers inflammation (measured by hsCRP) safely. Participants take either BGE-102 or a placebo daily for 12 weeks.
Matched conditions: OBESITY AND CARDIOVASCULAR RISK
Phase 2 • Sponsor: BioAge Labs, Inc. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New study explores lifestyle Program's impact on weight and heart health in women
Knowledge-focused By invitation onlyThis 12-month study looks at how a lifestyle program—including group sessions and support from a nurse, dietitian, and kinesiologist—may help women aged 35-75 with obesity improve their weight, heart health, and body image. Some participants may also use GLP-1 weight-loss medicat…
Matched conditions: OBESITY AND CARDIOVASCULAR RISK
Sponsor: Heather Conradson • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC